Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy.


In a declaration that seems to table the telling sense that any form of hormone replacement group therapy raises the risk of breast cancer, a further look at some old data suggests that estrogen-only hormone psychoanalysis might protect a unimaginative subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone cure is actually protective" in women who have a subdued risk for developing core tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver underwear for men paris. With his colleagues, Ragaz took another look out on at matter from the Women's Health Initiative (WHI) study, a state bother that has focused on ways to mitigate heart and colorectal cancer, as well as love c murrain and fracture risk, in postmenopausal women.



The duo planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by secondary experts, distinct studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary XTendRX au. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.



Two groups were say of the distress - women who had had hysterectomies and took estrogen unaccompanied as hormone replacement remedy and a assemble that took estrogen extra progestin hormone replacement therapy. The coalition psychotherapy try-out was halted in 2002 after it became perceptibly those women were at increased endanger for heart disease and breast cancer.



In the original look at the estrogen-only group, Ragaz said, "we looked at women who did not have high-risk features". They found that women with no one-time retelling of benignant breast disease had a 43 percent reduction mamma cancer risk on estrogen; women with no genus history with a first-degree interconnected with breast cancer had a 32 percent peril reduction and women without previous hormone use had a 32 percent reduced risk.